Skip to main content
Clinical Trials/NCT03124927
NCT03124927CompletedNot Applicable

Accuracy of Methemoglobin Measurement for Rainbow DCI Sensors

Masimo Corporation4 sites in 1 country25 target enrollmentStarted: April 23, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
25
Locations
4
Primary Endpoint
Accuracy of Sensor by Arms Calculation

Study Overview

Brief Summary

In this study, the level of methemoglobin (HbMet) will be increased in a controlled manner by administering sodium nitrite intravenously in healthy volunteers. The accuracy of a noninvasive HbMet measurement by a DCI pulse oximeter sensor will be assessed by comparison to blood measurements from a laboratory analyzer.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects must understand and consent to be in the study
  • American Society of Anesthesiology Class I (Healthy subjects without any systemic disease at all).

Exclusion Criteria

  • Subjects who have any systemic disease at all.
  • Subjects who do not understand the study and the risks involved.
  • Current smokers.
  • Subjects who are pregnant.

Outcomes

Primary Outcomes

Accuracy of Sensor by Arms Calculation

Time Frame: 5 hours

Accuracy will be determined by comparing the noninvasive blood methemoglobin measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials